Tonix Pharmaceuticals (TNXP) Reports Q3 Loss of $0.29/Share
Tweet
Share
E-mailGet Alerts TNXP Hot Sheet
Join SI Premium – FREE
Tonix Pharmaceuticals (NASDAQ: TNXP) reported Q3 EPS of ($0.29), versus ($0.72) reported last year.
For earnings history and earnings-related data on Tonix Pharmaceuticals (TNXP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gogoro Inc (GGR) Reports Q2 Loss of $0.24, Offers FY26 Revenue Guidance
- Citi maintains neutral stance on European equities despite rally
- Bernstein SocGen on StandardAero Inc (SARO): ' Solid revenues, but short-term margin issues'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
